Jim Cramer’s 5 Latest Stock Picks

4. AbbVie Inc (NYSE:ABBV)

Number of Hedge Fund Investors: 73

AbbVie Inc (NYSE:ABBV) was praised by Cramer because of its drugs, especially in the weight loss space. Cramer  said “great call” to the questioner in his program who had AbbVie Inc (NYSE:ABBV) in his portfolio based on weight loss-related catalysts. Cramer said AbbVie Inc (NYSE:ABBV) is a “very good company” and it has a lot of the “good drugs.”

AbbVie Inc (NYSE:ABBV) is a dividend aristocrat, having upped its payouts consistently over the past 25 years. CFRA recently published its dividend aristocrat stocks list. These companies have four-star and five-star ratings. AbbVie Inc (NYSE:ABBV) was part of the list.

Carillon Eagle Mid Cap Growth Fund made the following comment about AbbVie Inc. (NYSE:ABBV) in its Q3 2023 investor letter:

“AbbVie Inc. (NYSE:ABBV) reported strong, broad-based second-quarter performance that exceeded analysts’ expectations. The company’s raised guidance was a nice recovery after its mildly disappointing first-quarter report.”